Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Valensa Solidifies Partnerships - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Valensa Solidifies Partnerships

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Eustis, FL-based Valensa International and UAS Laboratories, Eden Prairie, MN, have entered a license and supply agreement that provides UAS access to Valensa’s patented Cran-Gyn ingredient for use in a new, patent-pending “triple action” women’s health product called Cran-Gyn DDS. This product combines Lactobacillus acidophilus DDS probiotics with Cran-Gyn—a concentrated, proprietary cranberry/d-mannose formulation. Cran-Gyn DDS offers a low-calorie, natural alternative to women for the management of urinary tract infection issues and yeast health management, as well as improvement of digestive health and immune function, in a low calorie easy-to-use dosage form with low “pill burden.” Valensa began the collaboration with UAS to explore the synergistic effects of probiotic products with the functioning of cranberry juice anthocyanins and natural d-mannose, along with immunity boosters and antioxidants that are present in Cran-Gyn.

Valensa has also entered a license agreement with Biova, LLC, Johnston, IA, which will allow Valensa to include the patented BiovaFlex water-soluble eggshell membrane ingredient in a new series of proprietary joint health products. Valensa was also granted a worldwide exclusive license for BiovaFlex in gummy-type chewables for joint health. BiovaFlex is a proprietary, natural ingredient rich in beneficial proteins, such as elastin, collagens and glycosaminoglycans (chondroitin-sulfate, glucosamine and hyaluronic acid), designed to support the stability and flexibility of synovial joint functions.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics